Publications by Razvan Tudor Radulescu in Truthfinding Cyberpress (TFCP) journals (http://im1.biz):

1.         Radulescu, R.T. and Schulze, J. 2002. Insulin-retinoblastoma  protein  (RB) complex  further  revealed: intracellular  RB  is  recognized  by  agarose-coupled insulin  and  co-immunoprecipitated  by  an  anti-insulin  antibody. Logical Biol. 2: 2-10.

2.         Radulescu, R.T. 2003. Oncoprotein-induced “conformational mutation“ of a tumor suppressor as an early event in oncogenesis: a novel concept. Logical Biol. 3: 16-17.

3.        Radulescu, R.T. 2003. Particle biology: at the interface between physics and  metabolism. Logical Biol. 3: 18-34.

4.        Radulescu, R.T. 2003. Ribonucleoprotein- and NADH-oxidoreductase-like prion protein: revisiting a structure-based prediction. Logical Biol. 3: 35.

5.         Radulescu, R.T. 2003. Potential of retinoblastoma protein to block insulin receptor activation by insulin: structural and experimental clues to a novel anti-dogma on a dual inhibition of cancer and ageing. Logical Biol. 3: 40-42.

6.         Radulescu, R.T. 2003. LXCXE motif and bipartite nuclear localization sequence in human transferrin: potential for complex formation with retinoblastoma protein in the cell nucleus. Logical Biol. 3: 43-44.

7.         Radulescu, R.T. and Kehe, K. 2003. MCR peptide MCR-4 inhibits the growth of human non-small cell lung cancer through a caspase-independent, p21-dependent pathway. Logical Biol. 3: 45-55.

8.         Radulescu, R.T. 2004. Putative oxygen binding site in retinoblastoma protein (RB): implications for tumor suppression and beyond. Logical Biol. 4: 75-77.

9.         Radulescu, R.T. 2004. Sequences similar to nociceptin/orphanin FQ and the ß-endorphin carboxyterminus in retinoblastoma protein (RB): potential for antagonism of opioids and immune stimulation in a tumor suppressor. Logical Biol. 4: 78-80.

10.       Radulescu, R.T. 2004. Signal peptide-like sequence in retinoblastoma protein (RB): the signature for the secretion of a nuclear tumor suppressor. Logical Biol. 4: 81-83.

11.       Radulescu, R.T. 2004. Sequence patterns in the aminoterminus of the tumor suppressor retinoblastoma protein (RB) reminiscent of cyclin E, Bcl-2 and the E7 viral oncoprotein: proposed RB cell survival motifs. Logical Biol. 4: 84-87.

12.       Radulescu, R.T. 2004. Switching on tumor suppression: a putative calcium binding site in retinoblastoma protein (RB). Logical Biol. 4: 102-103.

13.       Radulescu, R.T. 2004. The right spirit and climate for discovery. Logical Biol. 4: 104-105.

14.       Radulescu, R.T. 2005. From discovery to development: the special case requiring additional catalysts. Logical Biol. 5: 1-2.

15.       Radulescu, R.T. 2005. Zinc-binding motif similarity between retinoblastoma protein (RB) and insulin-degrading enzyme (IDE): insulin degradation as a potential tumor suppression principle. Logical Biol. 5: 3-6.

16.       Radulescu, R.T. 2005. Retinoblastoma protein (RB): a triply allosteric protein candidate. Logical Biol. 5: 7-8.

17.       Radulescu, R.T. 2005. Two elements of particle biology revisited. Logical Biol. 5: 9-10.

18.       Radulescu, R.T. 2005. Revealing the secret of life: insights from retinoblastoma protein (RB) and particle biology. Logical Biol. 5: 11-12.

19.       Radulescu, R.T. 2005. Invisible field beyond visible cells: it is time to jump over a "Berlin wall" in cancer research. Logical Biol. 5: 13-16.

20.       Radulescu, R.T. 2005. Disconnecting cancer cybernetics through a dual anti-nucleocrine strategy: towards an anticipatory therapy of malignant disease. Logical Biol. 5: 17-29.

21.       Radulescu, R.T. 2005. Proteins and peptides: back to the future. Logical Biol. 5: 56-57.

22.       Radulescu, R.T. 2005. Similarity between insulin and the glucocorticoid receptor: old and new consequences. Logical Biol. 5: 85-86.

23.       Radulescu, R.T. 2005. Normal cells first: a possible Copernican turn in cancer therapy. Logical Biol. 5: 87-88.

24.       Radulescu, R.T. 2005. On mass, motion, speed, force and energy in molecular biology: implications for cancer. Logical Biol. 5: 95-97.

25.       Radulescu, R.T. 2005. From particle biology to protein and peptide strings: a new perception of life at the nanoscale. Logical Biol. 5: 98-100.

26.       Radulescu, R.T. and Liu, S.V. 2005. Theoretical biology: the incipient revolution. Logical Biol. 5: 101.

27.       Radulescu, R.T. 2005. The blood coagulation cascade as an auxiliary tumor suppression and antimetastasis system. Logical Biol. 5: 117-121.

28.       Radulescu, R.T. 2005. Potential extracellular roles of the tumor suppressor retinoblastoma protein (RB): insulin-binding protein and beyond. Logical Biol. 5: 122-124.

29.       Radulescu, R.T. 2005. Immortalization without transformation. Logical Biol. 5: 142-143.

30.       Radulescu, R.T. 2005. Putative extracellular matrix binding site in insulin: a new window on the driving force for cancer cell metastasis. Logical Biol. 5: 144-145.

31.       Radulescu, R.T. 2005. Similarity between insulin and influenza virus haemagglutinin may underlie autoimmune genesis of diabetes mellitus. Logical Biol. 5: 146-147.

32.       Radulescu, R.T. 2005. Multiple sequence homologies between retinoblastoma protein (RB) and the anti-aging molecule Klotho. Logical Biol. 5: 148-150.

33.       Radulescu, R.T. 2006. From predicting the insulin-retinoblastoma protein complex to particle biology and beyond. Logical Biol. 6: 2-4.

34.       Radulescu, R.T. 2006. In resveratrol veritas: grape constituent vindicates anti-dogma on retinoblastoma protein´s double suppression of aging and cancer. Logical Biol. 6: 24-26.

35.       Radulescu, R.T. 2006. Immortalization without transformation: telomerase experiments vindicate retinoblastoma protein-based hypothesis. Logical Biol. 6: 35-36.

36.       Radulescu, R.T. 2006. On the origin of the term "particle biology". Logical Biol. 6: 37-38.

37.       Radulescu, R.T. 2006. Peptide strings in detail: first paradigm for the theory of everything (TOE). Pioneer 1: 62-68.

38.       Radulescu, R.T. 2006. Defensology: a universal theory of host defense against microbial infection, inflammation and cancer involving retinoblastoma protein (RB). Int. Med. 1: 12-17.

39.       Radulescu, R.T. 2006. Insulin-RB heterodimer: potential involvement in the linkage between aging and cancer. Logical Biol. 6: 81-83.

40.      Radulescu, R.T. 2006. Inactivation of retinoblastoma protein as the "missing link" between distinct models of aging. Logical Biol. 6: 93-94.

41.       Radulescu, R.T. 2006. Further evidence for the emerging paradigm of an association of cancer and senescence at the molecular level. Logical Biol. 6: 95-96.

42.       Radulescu, R.T. 2006. Retinoblastoma protein is superior to p53. Logical Biol. 6: 97-98.

43.       Radulescu, R.T. 2006. Why peptides may have enabled life on Earth. Logical Biol. 6: 99-100.

44.      Radulescu, R.T. 2006. Amyloidogenic prion fragment: defensive rather than pathogenic. Logical Biol. 6: 101-102.

45.       Radulescu, R.T. 2006. Ten putative glycosylation sites of retinoblastoma protein: molecular clues to an RB "glue". Logical Biol. 6: 113-114.

46.       Radulescu, R.T. 2006. Retinoblastoma protein may contact growth hormone: connecting DNA damage repair with metabolic silencing. Int. Med. 1: 18-19.

47.       Radulescu, R.T. 2006. Beyond Gulliver´s travels: on dwarfs, giants and a putative RB counterbalance to GH in aging. Int. Med. 1: 20-21.

48.       Liu, S.V., Zhang, J.J. and Radulescu, R.T. 2007. The declaration of revolution. Pioneer 2: 1-3.

49.       Liu, S.V. and Radulescu, R.T. 2007. A true revolution in scientific publishing- the TFCP statement. Pioneer 2: 4-6.

50.       Radulescu, R.T. 2007. Science and art: even more akin than hitherto presumed. Pioneer 2: 23-24.

51.       Radulescu, R.T. 2008. On a particular IgA1 as substance X in rheumatoid arthritis: a further molecular pursuit of Hench´s legacy. Int. Med. 3: 1-2.

52.       Radulescu, R.T. 2009. Insulin-degrading enzyme (IDE): potential member of an emerging family of ancient host defense molecules. Logical Biol. 9: 1-2.